Glimiron MV 2mg/500mg/0.3mg Tablet SR
Marketer
Biotas Health Care Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimiron MV 2mg/500mg/0.3mg Tablet SR
Diabetacrin SR, a 2mg/500mg/0.3mg combination tablet, is an antidiabetic medication for adult type 2 diabetes management. This formulation helps regulate blood glucose. Diabetacrin SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to manage this. Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, upper respiratory infections, and weight gain. Diabetacrin SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) may be recommended.
Uses of Glimiron MV 2mg/500mg/0.3mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glimiron MV 2mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimiron MV 2mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet on an empty stomach.
Common Side effects of Glimiron MV 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimiron MV 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimiron MV 2mg/500mg/0.3mg Sustained-Release Tablets should be taken on an empty stomach.
How Glimiron MV 2mg/500mg/0.3mg Tablet SR works:
The extended-release tablet, Glimiron MV 2mg/500mg/0.3mg, contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Glimiron MV 2mg/500mg/0.3mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiron MV 2mg/500mg/0.3mg Sustained-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimiron MV tablets (2mg/500mg/0.3mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimiron MV 2mg/500mg/0.3mg sustained-release tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Glimiron MV 2mg/500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimiron MV 2mg/500mg/0.3mg Tablet SR :
Should you forget to take a Glimiron MV 2mg/500mg/0.3mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimiron MV 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently